FRX Related Company Press Releases

May 17, 2013 08:08 AM Forest to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society (ATS) International Conference

May 16, 2013 08:00 AM Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting

May 14, 2013 08:00 AM Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013

May 9, 2013 06:00 AM Trevena, Inc. and Forest Laboratories Announce a Collaborative Agreement For Development of TRV027 for the Treatment of Acute Heart Failure

May 9, 2013 06:00 AM Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure

May 1, 2013 02:17 PM Forest Laboratories and Almirall Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol combination in COPD

Apr 23, 2013 07:00 AM Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2013 Earnings Per Share of $0.17 Including $0.08 Per Share of Acquisition Amortization

Apr 16, 2013 02:30 AM Almirall and Forest Laboratories Announce Positive Phase III Study Results for Aclidinium and Formoterol Combination in COPD

Apr 2, 2013 10:07 AM Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Fourth Quarter Earnings